Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
5,300
Employees5,300
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
5,300
Employees5,300

GMED Key Statistics

Market cap
11.76B
Market cap11.76B
Price-Earnings ratio
28.41
Price-Earnings ratio28.41
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$88.71
High today$88.71
Low today
$87.31
Low today$87.31
Open price
$87.61
Open price$87.61
Volume
590.97K
Volume590.97K
52 Week high
$94.93
52 Week high$94.93
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $87.31, with a market capitalization of 11.76B. The stock trades at a price-to-earnings (P/E) ratio of 28.41.

On 2025-12-31, Globus Medical(GMED) stock traded between a low of $87.31 and a high of $88.71. Shares are currently priced at $87.31, which is 0.0% above the low and -1.6% below the high.

Globus Medical(GMED) shares are trading with a volume of 590.97K, against a daily average of 1.17M.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $94.93 at its peak.

GMED News

Simply Wall St 7d
Globus Medical: Assessing Valuation After a 60% Three-Month Share Price Surge

Globus Medical (GMED) has quietly outperformed many medical device peers over the past 3 months, with shares climbing roughly 60%, prompting investors to revisi...

Globus Medical: Assessing Valuation After a 60% Three-Month Share Price Surge

Analyst ratings

56%

of 16 ratings
Buy
56.3%
Hold
37.5%
Sell
6.3%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.